Development of chimeric forms of the matrix metalloproteinase 2 collagen binding domain as artificial membrane binding proteins for targeting stem cells to cartilage lesions in osteoarthritic joints. (2022)
Attributed to:
Supercharged protein-surfactant bioconjugates for next-generation cell therapies
funded by
UKRI FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.biomaterials.2022.121547
PubMed Identifier: 35533445
Publication URI: http://europepmc.org/abstract/MED/35533445
Type: Journal Article/Review
Volume: 285
Parent Publication: Biomaterials
ISSN: 0142-9612